Wealthfront Advisers’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.4M | Sell |
56,285
-10,015
| -15% | -$2.77M | 0.02% | 238 |
|
|
2026
Q1 | $19.6M | Buy |
66,300
+1,393
| +2% | +$414K | 0.04% | 149 |
|
|
2025
Q4 | $17.7M | Buy |
64,907
+5,823
| +10% | +$1.58M | 0.04% | 146 |
|
|
2025
Q3 | $16M | Sell |
59,084
-1,735
| -3% | -$472K | 0.04% | 153 |
|
|
2025
Q2 | $16.8M | Buy |
60,819
+8,924
| +17% | +$2.43M | 0.04% | 137 |
|
|
2025
Q1 | $13.8M | Buy |
51,895
+6,418
| +14% | +$1.58M | 0.04% | 155 |
|
|
2024
Q4 | $10.6M | Buy |
45,477
+5,391
| +13% | +$1.24M | 0.03% | 173 |
|
|
2024
Q3 | $8.84M | Buy |
40,086
+1,669
| +4% | +$345K | 0.03% | 184 |
|
|
2024
Q2 | $7.55M | Sell |
38,417
-804
| -2% | -$166K | 0.03% | 189 |
|
|
2024
Q1 | $8.44M | Sell |
39,221
-8,516
| -18% | -$1.79M | 0.03% | 165 |
|
|
2023
Q4 | $10.1M | Buy |
47,737
+2,153
| +5% | +$459K | 0.04% | 135 |
|
|
2023
Q3 | $9.13M | Buy |
45,584
+9,646
| +27% | +$1.92M | 0.04% | 132 |
|
|
2023
Q2 | $6.66M | Buy |
35,938
+799
| +2% | +$148K | 0.03% | 174 |
|
|
2023
Q1 | $6.73M | Buy |
35,139
+8,950
| +34% | +$1.62M | 0.03% | 163 |
|
|
2022
Q4 | $4.4M | Buy |
26,189
+18,015
| +220% | +$3.13M | 0.02% | 225 |
|
|
2022
Q3 | $1.45M | Sell |
8,174
-19,583
| -71% | -$3.87M | 0.01% | 431 |
|
|
2022
Q2 | $5.68M | Buy |
27,757
+10,932
| +65% | +$2.32M | 0.03% | 166 |
|
|
2022
Q1 | $4M | Buy |
16,825
+3,394
| +25% | +$797K | 0.02% | 249 |
|
|
2021
Q4 | $3.07M | Buy |
13,431
+3,678
| +38% | +$809K | 0.01% | 301 |
|
|
2021
Q3 | $1.89M | Sell |
9,753
-1,669
| -15% | -$338K | 0.01% | 362 |
|
|
2021
Q2 | $2.43M | Buy |
11,422
+971
| +9% | +$205K | 0.01% | 267 |
|
|
2021
Q1 | $2.13M | Buy |
10,451
+1,577
| +18% | +$311K | 0.01% | 247 |
|
|
2020
Q4 | $1.61M | Buy |
8,874
+168
| +2% | +$28.6K | 0.01% | 277 |
|
|
2020
Q3 | $1.46M | Sell |
8,706
-330
| -4% | -$55.6K | 0.01% | 242 |
|
|
2020
Q2 | $1.47M | Sell |
9,036
-542
| -6% | -$97.2K | 0.01% | 234 |
|
|
2020
Q1 | $1.66M | Sell |
9,578
-2,579
| -21% | -$513K | 0.02% | 169 |
|
|
2019
Q4 | $2.44M | Sell |
12,157
-560
| -4% | -$115K | 0.02% | 143 |
|
|
2019
Q3 | $2.69M | Buy |
12,717
+468
| +4% | +$97.8K | 0.02% | 125 |
|
|
2019
Q2 | $2.38M | Buy |
12,249
+927
| +8% | +$171K | 0.02% | 135 |
|
|
2019
Q1 | $1.86M | Sell |
11,322
-3,258
| -22% | -$576K | 0.02% | 158 |
|
|
2018
Q4 | $2.74M | Buy |
+14,580
| New | +$2.69M | 0.03% | 97 |
|
Other funds holding CME
AI
Wealthfront Advisers's CME Position: Q2 2026 in Review
Wealthfront Advisers reduced its CME Group (CME) stake by 15% in Q2 2026, selling an estimated $2.77M and leaving 56,285 shares worth $12.4M. The position accounts for 0.02% of the portfolio, ranked #238.
Wealthfront Advisers first reported a position in CME in Q4 2018 and has held it in 31 quarters since. The position peaked at $19.6M in Q1 2026. 1,231 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Wealthfront Advisers held 56,285 shares of CME Group worth $12.4M as of Q2 2026.
- Wealthfront Advisers sold 10,015 CME Group shares in Q2 2026, an estimated $2.77M.
- CME Group made up 0.02% of Wealthfront Advisers's portfolio in Q2 2026, its #238 holding.
- Wealthfront Advisers first reported a position in CME Group in Q4 2018 and has held it in 31 quarters since.
- Wealthfront Advisers's CME Group position peaked at $19.6M in Q1 2026.
- 1,231 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.